The Panomles Approach in Neurodegenerative Disorders

被引:3
|
作者
Szatmari, Balazs [1 ]
Balicza, Peter [2 ]
Nemeth, Gyorgy [1 ]
Molnar, Maria Judit [2 ]
机构
[1] Gedeon Richter Plc, Med Div, Budapest, Hungary
[2] Semmelweis Univ, Inst Genom Med & Rare Dis Orders, Budapest, Hungary
关键词
Omics; classification; neurodegenerative disorders; multidisciplinary approach; genetics; imaging; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; PARKINSONS-DISEASE; TREM2; VARIANTS; PET; PATHOLOGY; NEUROINFLAMMATION; SAFETY;
D O I
10.2174/0929867324666170705120038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The molecular genetic technologies revolutionized the diagnostics of many disorders. Thanks to the new molecular techniques and the rapid improvement of the information technologies the number of mendelien inherited disorders has increased rapidly in the last five years. The omics era brought radical changes in the understanding of complex disorders and the underlying pathomechanisms. However, in most complex disorders the genome wide association studies could not clarify the genetic background even for disorders where a very strong heritability had been observed. Objective: In this paper the changing concept of the neurodegenerative disorders is discussed. The traditional classification of these disorders was purely based on clinical symptoms and morphological signs in the last century. Identifying the signature lesions of various neurodegenerative disorders may reveal a common pathological pathway in these disorders, New neuroimaging methods provided additional tools to assess pathological pathways in vivo already in the early stages of the diseases, Visualizing in vivo amyloid deposits and neuroinflammation improved our understanding of their role in various neurodegenerative disorders. Genetics may be the most precise way to identify the background of these disorders, However, there is only limited number of cases where true association can he proved between the disorder and the genetic mutations. Most of the neurodegenerative disorders seem to be multifactorial and cannot be traced back to one single cause. Conclusion: In conclusion, shifting from a classification based on symptomatology only to a modern multidisciplinary approach, based on the constantly evolving panomics findings, would improve our understanding of neurodegenerative diseases and could be the basis of novel therapeutic research.
引用
收藏
页码:1712 / 1720
页数:9
相关论文
共 50 条
  • [41] NEURODEGENERATIVE DISORDERS AND HYPERALDOSTERONISM
    SIMOPOULOS, AP
    DELEA, CS
    BARTTER, FC
    JOURNAL OF PEDIATRICS, 1971, 79 (04): : 633 - +
  • [42] Selected Neurodegenerative Disorders
    Pal, Somnath
    US PHARMACIST, 2012, 37 (01) : 6 - 6
  • [43] Apoptosis in neurodegenerative disorders
    Mark P. Mattson
    Nature Reviews Molecular Cell Biology, 2000, 1 : 120 - 130
  • [44] Iron in neurodegenerative disorders
    Berg, D.
    Becker, G.
    Riederer, P.
    Riess, O.
    NEUROTOXICITY RESEARCH, 2002, 4 (7-8) : 637 - 653
  • [45] Nanotechnology for neurodegenerative disorders
    Re, Francesca
    Gregori, Maria
    Masserini, Massimo
    MATURITAS, 2012, 73 (01) : 45 - 51
  • [46] Phosphodiesterases in neurodegenerative disorders
    Bollen, Eva
    Prickaerts, Jos
    IUBMB LIFE, 2012, 64 (12) : 965 - 970
  • [47] Imaging in Neurodegenerative Disorders
    Aralasmak, Ayse
    Kocak, Mehmet
    SEMINARS IN ROENTGENOLOGY, 2010, 45 (02) : 126 - 136
  • [48] Sleep in neurodegenerative disorders
    Happe, S.
    Mayer, G.
    NERVENARZT, 2006, 77 (10): : 1251 - 1259
  • [49] Neuroregeneration in neurodegenerative disorders
    Ana M Enciu
    Mihnea I Nicolescu
    Catalin G Manole
    Dafin F Mureşanu
    Laurenţiu M Popescu
    Bogdan O Popescu
    BMC Neurology, 11
  • [50] NEURODEGENERATIVE DISORDERS - REPLY
    COKER, SB
    NEUROLOGY, 1992, 42 (07) : 1432 - 1432